Odyssey Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Odyssey Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ODTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001882782
- EIN
- 86-3384382
Board of directors
-
Aranicki Ksenija Pavletic · DirectorSince 2026
-
Carolyn Ng · DirectorSince 2026
-
Gary D. Glick · Director · See RemarksSince 2026
-
Ian F. Smith · DirectorSince 2026
-
Jeffrey M. Leiden · DirectorSince 2026
-
Nan (Ln) Li · DirectorSince 2026
-
Ourania Tatsis · DirectorSince 2026
-
Paulina Hill · DirectorSince 2026
-
Shelley Chu · DirectorSince 2026
- Since 2026
-
Valerie Odegard · DirectorSince 2026
Board connections
4 of this board's directors also sit on 11 other boards.
- via Carolyn Ng
- via Timothy P. Walbert
- via Timothy P. Walbert
- via Ian F. Smith
- via Timothy P. Walbert
- via Timothy P. Walbert
- via Timothy P. Walbert
- via Timothy P. Walbert
- via Ian F. Smith
- via Ian F. Smith
- via Jeffrey M. Leiden
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $75,319,986
- 9 purchases by 7 insiders
- Sold, last 12 months
- $32,040
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 2026 | James G. Coulter Former 10% Owner | Other | +423,111 | — | — |
| May 11, 2026 | Simeon George 10% owner | Derivative conversion | +474,048 | — | — |
| May 11, 2026 | Nan (Ln) Li Director | Derivative conversion | +1,709,543 | — | — |
| May 11, 2026 | Shelley Chu Director | Open-market purchase | +11,111 | $18.00 | $199,998 |
| May 11, 2026 | Gary D. Glick Director, Officer (See Remarks) | Derivative conversion | +27,386 | — | — |
| May 11, 2026 | Opipari Anthony W. Officer (See Remarks) | Derivative conversion | +6,965 | — | — |
| May 11, 2026 | James G. Coulter Former 10% Owner | Other | −2,351 | $18.00 | $42,318 |
| May 11, 2026 | Simeon George 10% owner | Derivative conversion | +139,366 | — | — |
| May 11, 2026 | Jeffrey M. Leiden Director | Derivative conversion | +28,698 | — | — |
| May 11, 2026 | Nan (Ln) Li Director | Open-market purchase | +1,111,111 | $18.00 | $19,999,998 |
| May 11, 2026 | Opipari Anthony W. Officer (See Remarks) | Option exercise | +541 | — | — |
| May 11, 2026 | James G. Coulter Former 10% Owner | Derivative conversion | +1,880,497 | — | — |
| May 11, 2026 | Simeon George 10% owner | Derivative conversion | +59,692 | — | — |
| May 11, 2026 | Jeffrey M. Leiden Director | Option exercise | +2,963 | — | — |
| May 11, 2026 | Opipari Anthony W. Officer (See Remarks) | Shares withheld for tax | −4 | $18.00 | $72 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.